UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Visceral Leishmaniasis Masquerading as Drug-Induced Pancytopenia in Lung Cancer Patients

Current oncology (Toronto), 2024-04, Vol.31 (4), p.2274-2277

2024

Volltextzugriff (PDF)

Does the LENT score risk‐stratify patients with malignant pleural mesothelioma? An observational study

Thoracic cancer, 2021-06, Vol.12 (11), p.1752-1756

2021

Volltextzugriff (PDF)

Low lamin A expression in lung adenocarcinoma cells from pleural effusions is a pejorative factor associated with high number of metastatic sites and poor Performance status

PloS one, 2017-08, Vol.12 (8), p.e0183136-e0183136

2017

Volltextzugriff (PDF)

Rethought histologic classification of pleural mesothelioma to better treat: go forward from looking back

Translational lung cancer research, 2020-08, Vol.9 (4), p.1613-1616

Astoul, Philippe

2020

Volltextzugriff (PDF)

Anaplastic thyroid carcinoma mimicking a malignant pleural mesothelioma: Clues for diagnosis

Thoracic cancer, 2019-11, Vol.10 (11), p.2175-2178

2019

Volltextzugriff (PDF)

18F-fluoro-2-deoxy- d -glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients

Lung cancer (Amsterdam, Netherlands), 2013-02, Vol.79 (2), p.187-190

2013

Volltextzugriff (PDF)

Second-line treatment for advanced non-small cell lung cancer: A systematic review

Lung cancer (Amsterdam, Netherlands), 2006-02, Vol.51 (2), p.159-172

2006

Volltextzugriff (PDF)

Pleural Fluid Cytological Yield and Visceral Pleural Invasion in Patients with Epithelioid Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2012-03, Vol.7 (3), p.595-598

2012

Volltextzugriff (PDF)

Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma

Cancer, 2007-11, Vol.110 (10), p.2248-2252

2007

Volltextzugriff (PDF)

Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions

Oncotarget, 2016-01, Vol.7 (3), p.3357-3366

2016

Volltextzugriff (PDF)

Plasma Cell Membrane Localization of c-MET Predicts Longer Survival in Patients with Malignant Mesothelioma: A Series of 157 Cases from the MESOPATH Group

Journal of thoracic oncology, 2012-03, Vol.7 (3), p.599-606

2012

Volltextzugriff (PDF)

18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients Looking from outside is not enough

Lung cancer (Amsterdam, Netherlands), 2013-02, Vol.79 (2), p.187-190

2013

Volltextzugriff (PDF)

Thoracoscopic Assessment of Pleural Tumor Burden in Patients with Malignant Pleural Effusion: Prognostic and Therapeutic Implications

Journal of thoracic oncology, 2011-03, Vol.6 (3), p.592-597

2011

Volltextzugriff (PDF)

Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005

International journal of cancer, 2010-01, Vol.126 (1), p.232-238

2010

Volltextzugriff (PDF)

Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis

Lung cancer (Amsterdam, Netherlands), 2006-12, Vol.54 (3), p.423-425

2006

Volltextzugriff (PDF)

Miliary Mesothelioma: A New Clinical and Radiological Presentation in Mesothelioma Patients with Prolonged Survival After Trimodality Therapy

Journal of thoracic oncology, 2011-10, Vol.6 (10), p.1753-1756

2011

Volltextzugriff (PDF)

Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: A phase II study

Cancer, 1998-11, Vol.83 (10), p.2099-2104

1998

Volltextzugriff (PDF)

Intrapleural administration of lipoplatin in an animal model

Lung cancer (Amsterdam, Netherlands), 2011-04, Vol.72 (1), p.78-83

2011

Volltextzugriff (PDF)

Intrapleural Administration of Pemetrexed: A Pharmacokinetic Study in an Animal Model

Journal of thoracic oncology, 2009-03, Vol.4 (3), p.404-408

2009

Volltextzugriff (PDF)

Attributable risk in men in two French case-control studies on mesothelioma and asbestos

European journal of epidemiology, 2010-11, Vol.25 (11), p.799-806

2010

Volltextzugriff (PDF)

Non-small cell lung cancer—Smokers or non-smokers, does it matter?

Lung cancer (Amsterdam, Netherlands), 2009-03, Vol.63 (3), p.430-432

2009

Volltextzugriff (PDF)

Results and Impact of Routine Assessment of Comorbidity in Elderly Patients with Non–Small-Cell Lung Cancer Aged > 80 Years

Clinical lung cancer, 2007-03, Vol.8 (5), p.331-334

2007

Volltextzugriff (PDF)

Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura

Cancer, 1999-04, Vol.85 (8), p.1740-1749

1999

Volltextzugriff (PDF)

Alternating chemotherapy and accelerated split‐course irradiation in locally advanced nonsmall cell lung carcinoma

Cancer, 1999-05, Vol.85 (10), p.2144-2150

1999

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(28)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(26)
Humans
(24)
Male
(22)
Female
(15)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Middle Aged
(13)
Respiratory System
(13)
Aged
(12)
Mesothelioma - Pathology
(8)
Pneumology
(8)
Thoracoscopy
(8)
Tumors
(8)
Lung Cancer
(7)
Tumors Of The Respiratory System And Mediastinum
(7)
Adult
(6)
Chemotherapy
(6)
Aged, 80 And Over
(5)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Visceral Leishmaniasis Masquerading as Drug-Induced Pancytopenia in Lung Cancer Patients

Does the LENT score risk‐stratify patients with malignant pleural mesothelioma? An observational study

Low lamin A expression in lung adenocarcinoma cells from pleural effusions is a pejorative factor associated with high number of metastatic sites and poor Performance status

Rethought histologic classification of pleural mesothelioma to better treat: go forward from looking back

Anaplastic thyroid carcinoma mimicking a malignant pleural mesothelioma: Clues for diagnosis

18F-fluoro-2-deoxy- d -glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients

Second-line treatment for advanced non-small cell lung cancer: A systematic review

Pleural Fluid Cytological Yield and Visceral Pleural Invasion in Patients with Epithelioid Malignant Pleural Mesothelioma

Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma

Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions

Plasma Cell Membrane Localization of c-MET Predicts Longer Survival in Patients with Malignant Mesothelioma: A Series of 157 Cases from the MESOPATH Group

18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients Looking from outside is not enough

Thoracoscopic Assessment of Pleural Tumor Burden in Patients with Malignant Pleural Effusion: Prognostic and Therapeutic Implications

Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005

Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis

Miliary Mesothelioma: A New Clinical and Radiological Presentation in Mesothelioma Patients with Prolonged Survival After Trimodality Therapy

Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: A phase II study

Intrapleural administration of lipoplatin in an animal model

Intrapleural Administration of Pemetrexed: A Pharmacokinetic Study in an Animal Model

Attributable risk in men in two French case-control studies on mesothelioma and asbestos

Non-small cell lung cancer—Smokers or non-smokers, does it matter?

Results and Impact of Routine Assessment of Comorbidity in Elderly Patients with Non–Small-Cell Lung Cancer Aged > 80 Years

Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura

Alternating chemotherapy and accelerated split‐course irradiation in locally advanced nonsmall cell lung carcinoma

Standards, Options and Recommendations for the management of non-small cell lung carcinoma patients

Aktive Filter

Suchergebnisse filtern